Short-term effects of inhaled salbutamol on autonomic cardiovascular control in healthy subjects: A placebo-controlled study

British Journal of Clinical Pharmacology

Volumn 67, Issue 4, 2009, Pages 394-402

  Cekici, Leyla ^a   Valipour, Arschang ^a   Kohansal, Robab ^a   Burghuber, Otto Chris ^a  

^a OTTO WAGNER HOSPITAL   (Austria)

Author keywords

Haemodynamics; Heart rate variability; Inhaled 2 agonist

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; PLACEBO; SALBUTAMOL;

ADULT; ARTERIAL PRESSURE; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE VARIABILITY; BLOOD VESSEL TONE; BODY MASS; CARDIOVASCULAR FUNCTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; FEMALE; HEART OUTPUT; HEART RATE; HEMODYNAMIC MONITORING; HUMAN; HUMAN EXPERIMENT; MALE; NON INVASIVE MEASUREMENT; NORMAL HUMAN; PRIORITY JOURNAL; SHORT COURSE THERAPY; SINGLE BLIND PROCEDURE; SPIROMETRY; VASCULAR RESISTANCE;

ADMINISTRATION, INHALATION; ADULT; ALBUTEROL; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; FEMALE; HEART RATE; HEMODYNAMICS; HUMANS; MALE; SINGLE-BLIND METHOD; TREATMENT OUTCOME; YOUNG ADULT;

EID: 63849184085     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2009.03377.x     Document Type: Article

References (50)

1. Crane J, Pearce N, Flatt A, Burgess C, Jackson R, Kwong T, Ball M, Beasley R. Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study. Lancet 1989 I : 917 22.
2. Neville E, Corris PA, Vivian J, Nariman S, Gibson GJ. Nebulised salbutamol and angina. BMJ 1982 285 : 796 7.
3. Sears MR, Taylor DR, Print CG, Lake DC, Li Q, Flannery EM, Yates DM, Lucas MK, Herbison GB. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 1990 336 : 1391 6.
4. Sears MR. Short-acting beta-agonist research: a perspective 1997. Can Respir J 2001 8 : 349 55.
5. Spitzer WO, Suissa S, Ernst P. The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med 1992 326 : 501 6.
6. Suissa S, Blais L, Ernst P. Patterns of increasing beta-agonist use and the risk of fatal or near fatal asthma. Eur Respir J 1994 7 : 1602 9.
7. Au DH, Lemaitre RN, Curtis JR, Smith NL, Psaty BM. The risk of myocardial infarction associated with inhaled beta-adrenoceptor agonists. Am J Respir Crit Care Med 2000 161 : 827 30.
8. Pancu D, LaFlamme M, Evans E, Reed J. Levalbuterol is as effective as racemic albuterol in lowering serum potassium. J Emerg Med 2003 25 : 13 6.
9. Newton GE, Azevedo ER, Parker JD. Inotropic and sympathetic responses to the intracoronary infusion of a beta2-receptor agonist: a human in vivo study. Circulation 1999 99 : 2402 7.
10. Kallergis EM, Manios EG, Kanaupakis EM, Schiza SE, Mavrakis HE, Klapsinos NK, Vardas PE. Acute electrophysiologic effects of inhaled salbutamol in humans. Chest 2005 127 : 2057 63.
11. La Rovere MT, Bigger TH Jr., Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet 1998 351 : 478 84.
12. La Rovere MT, Pinna GD, Maestri R, Mortara A, Capomolla S, Febo O, Ferrari R, Franchini M, Gnemmi M, Opasich C, Riccardi PG, Traversi E, Cobelli F. Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients. Circulation 2003 107 : 565 70.
13. Kikuya M, Hozawa A, Ohokubo T, Tsuji I, Michimata M, Matsubara M, Ota M, Nagai K, Araki T, Satoh H, Ito S, Hisamichi S, Imai Y. Prognostic significance of blood pressure and heart rate variabilities: the Ohasama study. Hypertension 2000 36 : 901 6.
14. Fortin J, Marte W, Grüllenberger R, Hacker A, Habenbacher W, Heller A, Wagner CH, Wach P, Skrabal F. Continuous non-invasive blood pressure monitoring using concentrically interlocking control loops. Comput Biol Med 2006 36 : 941 57.
15. Fortin J, Habenbacher W, Heller A, Hacker A, Grüllenberger R, Innerhofer J, Passath H, Wagner C, Haitchi G, Flotzinger D, Pacher R, Wach P. Non-invasive beat-to beat cardiac output monitoring by an improved method of transthoracic bioimpedance measurement. Comput Biol Med 2006 36 : 1185 203.
16. Gratze G, Fortin J, Holler A, Grasenick K, Pfurtscheller G, Wach P, Schönegger J, Kotanko P, Skrabal F. A software package for non-invasive, real time beat to beat monitoring of stroke volume, blood pressure, total peripheral resistance and for assessment of autonomic function. Comput Biol Med 1998 28 : 121 42.
17. Taler SJ, Textor SC, Augustine JE. Resistant hypertension: comparing hemodynamic management to specialist care. Hypertension 2002 39 : 982 8.
18. Van de Water JM, Miller TW, Vogel RL, Mount BE, Dalton ML. Impedance cardiography. The next vital sign technology? Chest 2003 123 : 2028 33.
19. Bianchi AM, Mainardi LT, Meloni C, Chierchia S, Cerutti S. Continuous monitoring of the sympatho-vagal balance through spectral analysis. IEEE Eng Med Biol Mag 1997 16 : 64 73.
20. Schloegl A, Flotzinger D, Pfurtscheller G. Adaptive autoregressive modelling used for single trial EEG classification. Biomed Tech 1997 42 : 162 7.
21. Fritsch JM, Eckberg DL, Graves LD, Wallin BG. Arterial pressure ramps provoke linear increases of heart period in humans. Am J Physiol 1986 251 : R1086 90.
22. Watkins LL, Grossman P, Sherwood A. Noninvasive assessment of baroreflex control in borderline hypertension. Comparison with the phenylephrine method. Hypertension 1996 28 : 238 43.
23. Valipour A, Schneider F, Kössler W, Saliba S, Burghuber OC. Heart rate variability and spontaneous baroreflex sequences in supine healthy volunteers subjected to nasal positive airway pressure. J Appl Physiol 2005 99 : 2137 43.
24. Larsson S, Svedmyr N. Bronchodilating effect and side effects of ß-2-adrenoceptor stimulants by different modes of administration (tablets, metered aerosol, and combinations thereof); a study with salbutamol in asthmatics. Am Rev Respir Dis 1977 116 : 861 9.
25. Pierce RJ, Payne CR, Williams SJ, Denison DM, Clark TJHA. Comparison of intravenous and inhaled terbutaline in the treatment of asthma. Chest 1981 79 : 506 12.
26. Webb J, Rees J, Clark TJ. Comparison of different methods of administration of ß2-sympathomimetics in patients with asthma. Br J Dis Chest 1982 76 : 351 7.
27. Chapman KR, Smith DL, Rebuck AS, Leenen FH. Hemodynamic effects of an inhaled ß2 agonist. Clin Pharmcol Ther 1984 35 : 762 7.
28. Eryonucu B, Uzun K, Guler N, Bilge M. Comparison of the acute effects of salbutamol and terbutalin on heart rate variability in adult asthmatic patients. Eur Respir J 2001 17 : 863 7.
29. Jarrti T, Kaila T, Tahvanainen K, Kuusela T, Vanto T, Valikmaki I. The acute effects of inhaled salbutamol on the beat-to-beat variability of heart rate and blood pressure assessed by spectral analysis. Br J Clin Pharmacol 1997 43 : 421 8.
30. Kaya D, Barutcu I, Esen AM, Onrat E, Orman A, Unlu M. Comparison of the effects of ipratropium cromide and salbutamol on autonomic heart rate control. Europace 2004 6 : 602 7.
31. Rossinen J, Partanen J, Stenius-Aarniala B, Nieminen MS. Salbutamol inhalation has no effect on myocardial ischemia, arrhytmias and heart-rate variability in patients with coronary artery disease plus asthma or chronic obstructive pulmonary disease. J Intern Med 1998 243 : 361 6.
32. Graves J, Poston L. Beta-adrenoceptor agonist mediated relaxation of rat isolated resistance arteries: a role for the endothelium and nitric oxide. Br J Pharmacol 1993 108 : 631 7.
33. Appel ML, Berger RD, Saul JP, Smith JM, Cohen RJ. Beat to beat variability in cardiovascular variables: noise or music? J Am Coll Cardiol 1989 14 : 1139 48.
34. Pomeranz M, Macaulay RJB, Caudill MA. Assessment autonomic function in humans by heart rate spectral analysis. Am J Physiol Heart Circ Physiol 1985 248 : H151 3.
35. Malliani A. The pattern of sympathovagal balance explored in the frequency domain. News Physiol Sci 1999 14 : 111 7.
36. Task Force of the European Society of Cardiology, and the North American Society of Pacing and Electrophysiology. Heart Rate Variability: standards of measurement, physiological interpretation, and clinical use. Eur Heart J 1996 17 : 354 81.
37. Montano N, Ruscone TG, Porta A, Lombardi F, Pagani M, Malliani A. Power spectrum analysis of heart rate variability to assess the changes in sympathovagal balance during graded orthostatic tilt. Circulation 1994 90 : 1826 31.
38. Cogliati C, Magatelli R, Montano N, Narkiewicz K, Somers VK. Detection of low- and high-frequency rhythms in the variability of skin sympathetic nerve activity. Am J Physiol Heart Circ Physiol 2000 278 : H1256 60.
39. Pagani M, Montano M, Porta A, Malliani A, Abbound FM, Birkett C, Somers VK. Relationship between spectral components of cardiovascular variabilities and direct measures of muscle sympathetic nerve activity in humans. Circulation 1997 95 : 1441 8.
40. Tatasciore A, Renda G, Zimarino M, Soccio M, Bilo G, Parati G, Schillaci G, De Caterina R. Awake systolic blood pressure variability correlates with target-organ damage in hypertensive subjects. Hypertension 2007 50 : 325 32.
41. Pringle E, Phillips C, Thijs L, Davidson C, Staessen JA, de Leeuw PW, Jaaskivi M, Nachev C, Parati G, O'Brien ET, Tuomilehto J, Webster J, Bulpitt CJ, RH F. Syst-Eur investigators. Systolic blood pressure variability as a risk factor for stroke and cardiovascular mortality in the elderly hypertensive population. J Hypertens 2003 21 : 2251 7.
42. Akselrod S, Gordon D, Ubel FA, Shannon DC, Barger AC, Cohen RJ. Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat to beat cardiovascular control. Science 1981 213 : 220 2.
43. Waring SW, Leigh RB. Hemodynamic responses to salbutamol and isometric exercise in young adults with mild asthma. Eur J Clin Pharmacol 2005 61 : 9 14.
44. Silke B, Hanratty CG, Riddell JG. Heart-rate variability effects of beta-adrenoceptor agonists (xamoterol, prenalterol, and salbutamol) assessed nonlinearly with scatterplots and sequence methods. J Cardiovasc Pharmacol 1999 33 : 859 67.
45. Dagnone AJ, Parlow JL. Effects of inhaled albuterol and ipratropium bromide on autonomic control of the cardiovascular system. Chest 1997 111 : 1514 8.
46. Jartti T. Asthma, asthma medication and autonomic nervous system dysfunction. Clin Physiol 2001 21 : 260 9.
47. Lanes SF, Garcia-Rodriguez LA, Huerta C. Respiratory medications and risk of asthma death. Thorax 2002 57 : 683 6.
48. Salpeter SR, Ormiston TM, Salpeter EE. Cardiovascular effects of ß-agonists in patients with asthma and COPD: a meta-analysis. Chest 2004 125 : 2309 21.
49. Tsuji H, Venditti FJ Jr., Manders ES, Evans JC, Larson MG, Feldman CL, Levy D. Reduced heart rate variability and mortality risk in an elderly cohort. The Framingham Heart Study. Circulation 1994 90 : 878 83.
50. Walters EH, Gibson PG, Lasserson TJ, Walters JA. Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroid. Cochrane Database Syst Rev 2007 24 : CD001385.